Topic

California

A collection of 427 issues

How to Get Cabometyx (cabozantinib) Covered by UnitedHealthcare in California: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Cabometyx Covered by UnitedHealthcare in California Cabometyx (cabozantinib) requires prior authorization from UnitedHealthcare/OptumRx for all FDA-approved indications. Your fastest path to approval: (1) Ensure your oncologist submits a complete PA request with diagnosis, staging, and prior therapy documentation via the UnitedHealthcare provider portal, (2) If denied,

How to Get Gattex (teduglutide) Covered by Humana in California: Complete Prior Authorization & Appeals Guide

Answer Box: Getting Gattex (teduglutide) Covered by Humana in California Fastest path to approval: Submit prior authorization using Humana's California-specific PA form with detailed short bowel syndrome documentation. If denied, file internal appeal within 65 days, then escalate to California's Independent Medical Review (IMR) through DMHC

How to Get Ofev (Nintedanib) Covered by Cigna in California: Requirements, Appeals, and Success Strategies

Quick Answer: Getting Ofev (Nintedanib) Covered by Cigna in California Eligibility: Ofev requires prior authorization from Cigna for idiopathic pulmonary fibrosis (IPF) and systemic sclerosis-associated ILD (SSc-ILD). Fastest path: Have your pulmonologist submit a complete PA with HRCT results, PFTs showing FVC ≥40%, and medical necessity letter. First step today:

Get Pemazyre (Pemigatinib) Covered by UnitedHealthcare in California: Prior Authorization Guide and Appeal Scripts

Answer Box: Fastest Path to Pemazyre Coverage To get Pemazyre (pemigatinib) covered by UnitedHealthcare in California: You need prior authorization with documented FGFR2 fusion/rearrangement via FDA-approved testing, previous treatment history, and unresectable/metastatic cholangiocarcinoma diagnosis. Submit through UnitedHealthcare provider portal with complete molecular testing results. If denied, file internal

Myths vs. Facts: Getting Retevmo (selpercatinib) Covered by Blue Cross Blue Shield in California

Answer Box: Getting Retevmo Covered by Blue Cross Blue Shield California Myth: If your doctor prescribes Retevmo, Blue Cross Blue Shield must cover it. Fact: Prior authorization is required with specific RET alteration testing documentation. Fastest path: Submit PA with RNA-based NGS results showing RET fusion/mutation, prior therapy records,

How to Get Ilaris (Canakinumab) Covered by Blue Cross Blue Shield in California: Complete Prior Authorization and Appeal Guide

Quick Answer: Blue Cross Blue Shield California requires prior authorization for Ilaris (canakinumab) for Still's disease and SJIA. Submit PA request with rheumatologist prescription, weight-based dosing documentation, and diagnosis codes (M06.1 for AOSD, M08.2X for SJIA). If denied, California's Independent Medical Review has a

How to Get Evkeeza (evinacumab-dgnb) Covered by Cigna in California: Prior Authorization, Appeals, and Success Strategies

Quick Answer: Getting Evkeeza Covered by Cigna in California To get Evkeeza (evinacumab-dgnb) covered by Cigna in California for homozygous familial hypercholesterolemia (HoFH), you'll need prior authorization with genetic testing confirmation, documented failure of high-intensity statin plus ezetimibe, and (for ages 10+) a PCSK9 inhibitor trial. If denied,

Myths vs. Facts: Getting Rebif (interferon beta-1a) Covered by Aetna (CVS Health) in California

Answer Box: The Real Path to Rebif Coverage Rebif (interferon beta-1a) requires prior authorization from Aetna (CVS Health) in California, regardless of your doctor's prescription. Success depends on proper documentation—MS diagnosis, MRI evidence, and prior treatment history—not on common myths. If denied, you have 180 days

How to Get Blenrep (belantamab mafodotin) Covered by Aetna in California: Decision Tree, Appeals, and Access Options

Answer Box: Your Path to Blenrep Coverage in California Blenrep (belantamab mafodotin) is currently unavailable for commercial coverage through Aetna CVS Health because GSK withdrew it from the U.S. market in November 2022. The FDA is reviewing resubmission with a PDUFA date of October 23, 2025. Your fastest path

Get Orfadin (Nitisinone) Covered by UnitedHealthcare in California: Decision Tree & Appeal Guide 2025

Quick Answer: Do You Qualify for Orfadin Coverage? Yes, if you have: Confirmed hereditary tyrosinemia type 1 (HT-1) diagnosis with elevated succinylacetone levels, prescribed by a metabolic specialist, and following dietary restrictions. Fastest path: Submit prior authorization via UnitedHealthcare Provider Portal with HT-1 lab results, specialist letter, and dietary plan.